Talk:Gacyclidine

This is the talk page for discussing improvements to the Gacyclidine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Pharmacology Stub‑class Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Stub	This article has been rated as Stub-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

The diagram of the gacyclidine molecule should be edited to depict the racemate, as the name "gacyclidine" does not specify a single enantiomer. To quote a paper on the subject "Gacyclidine [cis(pipGme)]-1-[1-(2-thienyl)-2-methylcyclohexylpiperidine] (Fig. 2) is a PCP derivative bearing a 2-thienyl group as an aromatic moiety and a methyl group at carbon 2. The methyl group introduces a chiral center and, therefore, gacyclidine is a racemate of two enantiomers, (+)GK11 [(+)-(1R-2S)-1-[1-(2-thienyl)-2-methylcyclohex- ylpiperidine] and (–)GK11 [(–)-(1S-2R)-1-[1-(2-thienyl)-2-methylcyclohexylpiperidine]...Since it is a racemate, the binding characteristics of the two enantiomers have also been determined in parallel (41)."

so replace the hatches and wedges with straight lines or adders. Valerophenone (talk) 02:17, 9 February 2011 (UTC)[reply]